Karen Massey — SPARQNOW

At-a-Glance

Chief Executive Officer at argenx, a global immunology company focused on severe autoimmune diseases.
Leads efforts to advance patient-centric innovation and deliver breakthrough medicines.
Career experience includes roles at Genentech and Pfizer.
Previously worked as a Management Consultant at Bain & Company.

Biography

Karen Massey serves as the Chief Executive Officer of argenx, an independent global immunology company. In this role, she leads the company's mission to transform the lives of individuals living with severe autoimmune diseases. Her work emphasizes reimagining the development and delivery of medical innovation to ensure breakthrough medicines reach patients more quickly and effectively.